DocketNumber: No. 1223-98
Citation Numbers: 79 T.C.M. 1498, 2000 Tax Ct. Memo LEXIS 56, 2000 T.C. Memo. 50
Judges: "Cohen, Mary Ann"
Filed Date: 2/11/2000
Status: Non-Precedential
Modified Date: 4/18/2021
Decision will be entered under Rule 155.
MEMORANDUM FINDINGS OF FACT AND OPINION
COHEN, CHIEF JUDGE: Respondent determined the following deficiencies, additions to tax, and penalties with respect to petitioners' Federal income tax:
Sec. | Sec. | Sec. | Sec. | Sec. | Sec. | ||
1985 | $ 0 | $ 212 | $ 192 | $ 66 | $ - | $ - | $ - |
1986 | 5,282 | 2,991 | 1,572 | - | 827 | 5,282 | - |
1987 | 1,376 | 332 | 52 | - | 74 | 1,376 | - |
1988 | 2,921 | 774 | 861 | 172 | - | - | - |
1989 | 16,214 | 2,178 | 2,420 | - | - | - | 3,190 |
1990 | 41,339 | 11,067 | 12,051 | - | - | - | 8,132 |
1991 | 37,713 | 6,681 | 1,710 | - | - | - | 7,543 |
1992 | 49,979 | 9,940 | 1,254 | - | - | - | 9,954 |
1993 | 141,892 | 30,766 | 1,050 | - | - | - | 28,378 |
The issues for decision are: (1) The amount of losses sustained by petitioners from their investments in, loans made to, and loan guaranties for several pharmaceutical corporations between 1979 and 1984; (2) the years petitioners were entitled to recognize their losses; (3) whether the losses became part of the personal bankruptcy estate of petitioners; (4) the amount of carryover losses used by the personal bankruptcy estate of petitioners; *57 (5) the character of any remaining losses; and (6) whether petitioners are liable for penalties and additions to tax for 1985 through 1993. Other issues in the statutory notice or in the petition have been abandoned by petitioners because they failed to present any evidence or argument concerning them.
Unless otherwise indicated, all section references are to the Internal Revenue Code in effect for the years in issue, and all Rule references are to the Tax Court Rules of Practice and Procedure.
FINDINGS OF FACT
Some of the facts have been stipulated, and the stipulated facts are incorporated in our findings by this reference.
At the time of the filing of their petition, petitioners resided in Greenwich, Connecticut. Allen C. Chamberlin (petitioner) is a doctor of orthopedic medicine, having graduated from the Boston University School of Medicine. Petitioners filed their joint Forms 1040, U.S. Individual Income Tax Return, for 1982 through 1993 on the following dates:
1982 | 07/11/84 |
1983 | 09/06/94 |
1984 | 09/06/94 |
1985 | 09/17/88 |
1986 | 09/17/88 |
1987 | 09/17/88 |
1988 | 04/17/95 |
1989 | 04/04/95 |
1990 | 04/17/95 |
1991 | 03/27/95 |
1992 | 03/27/95 |
1993 | 10/16/95 |
The initial 1985, 1986, and 1987 Forms 1040 were blank and contained *58 no financial information. Subsequently, on December 28, 1994, petitioners filed completed Forms 1040 for these years. Petitioners reported $ 1,324, $ 11,264, $ 98, $ 521, $ 1,584, $ 7,849, $ 9,499, $ 10,450, and $ 11,057 of total tax on their returns for 1985, 1986, 1987, 1988, 1989, 1990, 1991, 1992, and 1993, respectively. Petitioners prepared their returns with the help of a certified public accountant.
Pharmacare, Inc. (Pharmacare), was a Delaware corporation engaged in the business of manufacturing unit dose pharmaceutical products and packaging cosmetic products and lotions. The main manufacturing facility for Pharmacare was located in Largo, Florida (Largo facility).
During 1978, Pharmacare was in serious financial difficulty and was looking for investors to provide working capital for the company. A group of investors led by Stelios Vavlitis (Vavlitis) agreed to invest funds in Pharmacare in exchange for a controlling interest in the outstanding stock of the corporation. Vavlitis planned to rebuild Pharmacare under his management and to attract other investors to provide working capital. Vavlitis created Pharmaco Trust, which bought an 87.6-percent interest in the outstanding *59 stock of Pharmacare and held the acquired stock for management and sales purposes. Vavlitis was made president, chief executive officer, and chairman of the board of directors of Pharmacare.
In 1978, Vavlitis persuaded petitioner to purchase three units of Pharmaco Trust for $ 99,000. In doing so, Vavlitis made material false representations and misstatements about his prior business experience, his educational background, Pharmacare's ownership of patents, and the amount of competition that Pharmacare faced in the marketplace. In 1979 and 1980, Vavlitis also persuaded petitioner to make substantial unsecured loans to Pharmacare in order to keep the company running. Vavlitis failed to provide promissory notes for these loans despite repeated requests by petitioner.
On June 12, 1980, creditors of Pharmacare filed a chapter 7 involuntary bankruptcy petition against the company in the U.S. Bankruptcy Court for the Middle Division of Florida. As an unsecured creditor of Pharmacare, petitioner did not receive any payment from the Pharmacare bankruptcy to reimburse his investment or his loans. On their Form 1040, U.S. Individual Income Tax Return for 1982, petitioners deducted a loss from *60 their Pharmacare investment and loans as a section 165 theft loss. Respondent audited the 1982 return and disallowed the loss.
On March 9, 1981, petitioner organized The Chamberlin Corporation (The Chamberlin Corp.), a Delaware corporation licensed to do business in Florida, for the purpose of continuing the Largo, Florida, operation. Petitioner became an 80-percent shareholder in The Chamberlin Corp., was elected chairman of the board of directors, and was hired as the chief executive officer. Petitioner did not receive a wage for the services he rendered in these positions. The Chamberlin Corp. purchased the inventory, intangible property, personal property, and equipment of Pharmacare from the trustee in bankruptcy for $ 200,000 and then immediately transferred ownership to petitioner. On September 18, 1981, in a three-party agreement, petitioner purchased the Largo facility from the Pharmacare trustee in bankruptcy by giving The Chamberlin Corp. a $ 183,800 promissory note and assuming $ 572,046 of debt secured by the property. The Chamberlin Corp. then paid $ 177,954 of Pharmacare debt on behalf of the trustee and $ 4,077 of transfer expenses. Petitioner rented the Largo facility *61 back to The Chamberlin Corp. from 1981 until 1984.
On November 3, 1982, petitioner obtained a personal loan from the Freedom Federal Savings & Loan Association (Freedom Federal) in the amount of $ 1,750,000. This loan was secured by a first mortgage on the principal residence of petitioners in Greenwich, Connecticut. Four hundred fifty thousand dollars of the loan proceeds was then reloaned by petitioner to The Chamberlin Corp. and used to pay off debts of The Chamberlin Corp. The Chamberlin Corp. also obtained loans from the Ingersoll-Rand Financial Corporation (Ingersoll-Rand) in the amount of $ 1,800,000, personally guaranteed by petitioner, and loans in the amounts of $ 750,000 and $ 250,000, secured by second mortgages on the Greenwich residence. Petitioner also personally guaranteed a loan of $ 300,000 from Ingersoll-Rand that was made to his incorporated medical practice.
In 1983, petitioner purchased Bel-Mar Laboratories (Bel- Mar), a company whose principal purpose was the manufacture of parenteral products. Parenteral describes liquid medication injected by syringe or needle directly into the bloodstream of a patient. Petitioner became the sole shareholder and chairman of the *62 board of directors of Bel-Mar, and he immediately changed the name to Chamberlin Parenteral, Inc. (Chamberlin Parenteral).
In 1984, The Chamberlin Corp. was unable to pay its debts, and, on December 17, 1984, creditors filed an involuntary chapter 11 bankruptcy petition against the company. Petitioner continued to search for outside investments to save the company, and the company continued to operate at least through March 1985. The assets of The Chamberlin Corp., including the Largo facility that had been surrendered to the corporation by petitioner, were sold to pay debts of the company in June 1985.
On July 11, 1985, petitioners filed a personal chapter 11 petition in bankruptcy. Petitioners did not make a
After filing their personal petition in bankruptcy, petitioners moved to California. All of their personal assets, which became the property of the bankruptcy estate, were placed in storage. Among these items were important business documents and tax records. Petitioners were unable to retrieve these documents because the bankruptcy estate failed to make the proper storage payments.
OPINION
Petitioners bear the burden of proving that the determinations in the notice of deficiency are erroneous and that they are entitled to any deductions claimed on their returns. See
Petitioners claim that they were the victims of theft at the hands of Vavlitis and, therefore, should be entitled to deduct their losses arising from their loans to and investment in Pharmacare as a section 165(c) theft loss. Petitioner also claims that he engaged in the trade or business of promoting pharmaceutical companies from 1978 to 1985 and, therefore, that he is entitled to deduct any losses arising from loans to or investment in Pharmacare, The Chamberlin Corp., and Chamberlin Parenteral as section 162(a) business expenses or
In coming to a decision on the issues in this case, it is necessary to calculate the amount of losses incurred by petitioners in years predating the tax years in issue. We do not have jurisdiction over years prior to 1985. See
In the capacity of a creditor, a taxpayer *65 realizes a loss from a loan made to a corporation that becomes worthless and uncollectible. The amount of loss from a worthless loan is the adjusted basis of the promissory note representing the debt. See
Amount of Losses
Petitioners claim to have suffered a loss in the amount of $ 1,255,400 from petitioner's dealings with Pharmacare. Respondent concedes that a loss was incurred by petitioners in the amount of $ 414,000 but contests the occurrence of the following transfers, which petitioners claim were loans made to Pharmacare:
Wire transfer | --/--/79 | $ 25,000 |
Checks | 10/19/79 | 10,000 |
10/19/79 | 10,000 | |
10/19/79 | 10,000 | |
10/19/79 | 10,000 | |
10/19/79 | 10,000 | |
11/19/79 | 16,000 | |
11/21/79 | 49,500 | |
12/05/79 | 33,000 | |
12/12/79 | 45,000 | |
Third party loan proceeds | 08/06/79 | 364,000 |
08/23/79 | 35,000 | |
08/24/79 | 120,000 | |
09/12/79 | 40,000 | |
07/01/80 | 30,000 | |
Miscellaneous loans | 05/--/79 | 30,000 |
06/--/79 | ||
Total | $ 841,400 |
Petitioners *66 have provided five canceled checks endorsed to Pharmacare totaling $ 56,000. Petitioners have also provided evidence of third-party loans made to petitioner and Vavlitis jointly in the amounts of $ 364,000, $ 35,000, and $ 40,000. Petitioners have shown that the proceeds from these loans were contributed or reloaned to Pharmacare by petitioner and that the loans were repaid with property of petitioner. With respect to the remaining contested transactions, petitioners rely on a proof of claim filed in the Pharmacare bankruptcy and dated April 28, 1982. Under the circumstances, we conclude that petitioners' minimal documents and testimony are sufficient to substantiate the amount of loss with respect to Pharmacare.
Petitioners also claim that they are entitled to recognize losses from petitioner's contributions to The Chamberlin Corp. and Chamberlin Parenteral. To substantiate their losses, petitioners have provided only a statement of net worth, prepared in 1982, that showed that petitioners' net worth was $ 6,032,052. They argue that their net worth fell to zero in 1985 as a result of The Chamberlin Corp. failure, and, therefore, they should be entitled to a loss of $ 6,032,052. Such *67 a statement, uncorroborated by receipts, expenses, or other documentation that reflects how assets were lost or disposed of, is insufficient for determining the amount of losses sustained by petitioners. See
Petitioners have provided documentation relating to a loan that was made from a third party to petitioner personally and loans that were made to The Chamberlin Corp., which were secured and satisfied by personal property of petitioner. First, petitioners argue that they are entitled to recognize $ 1,750,000 of loss stemming from a personal loan from Freedom Federal. Petitioner claims that he contributed or reloaned the entire amount of proceeds to The Chamberlin Corp. and Chamberlin Parenteral. Respondent argues that only $ 450,000 of the principal was reloaned to these corporations. Second, petitioners argue that they are entitled to losses stemming from funds that petitioner contributed to The Chamberlin Corp., which were used for operating capital *68 and the initial purchase of the Pharmacare assets in 1981.
Of the principal amount of the Freedom Federal loan, $ 450,000 was reloaned to The Chamberlin Corp. and used to repay a portion of a debt owed by The Chamberlin Corp. to E.F. Hutton Credit Corporation. Petitioner testified at trial that the remaining $ 1,300,000 of the Freedom Federal loan was used to purchase Bel-Mar, which later became Chamberlin Parenteral, and to provide working capital or to pay debts of The Chamberlin Corp. Petitioner also testified that he contributed all of the funds used by The Chamberlin Corp. to buy the assets of Pharmacare from the trustee in bankruptcy in 1981.
Petitioner has failed to provide sufficient evidence showing that the $ 1,300,000 of remaining principal was reloaned or contributed to either corporation or to show how much funding, if any, he provided to The Chamberlin Corp. for the asset purchases or startup costs. There is no contemporaneous corroboration of his generalized testimony. Therefore, petitioners' allowable losses from their contributions or reloans of the Freedom Federal loan proceeds to The Chamberlin Corp. or Chamberlin Parenteral are no more than $ 450,000.
The next argument *69 of petitioners, which respondent does not contest, is that petitioners' bankruptcy estate is entitled to a loss of $ 944,049 for its partial repayment of loans made by Ingersoll-Rand to The Chamberlin Corp. The loans, which totaled $ 2,900,000, were repaid to the extent of $ 944,049 by the bankruptcy estate of petitioners. A guarantor, such as petitioner, who pays part of a loan for a corporation in bankruptcy is deemed to have made a loan to the corporation for the amount paid to the creditor. The loan, deemed made to the corporation, is deductible as a worthless debt. See
TIMING OF LOSSES OF PETITIONERS
Petitioners argue that their $ 1,255,400 loss arising from Pharmacare should be recognizable in 1985, the year that the assets of The Chamberlin Corp. were sold in bankruptcy. This argument hinges upon a finding that The Chamberlin Corp. and Pharmacare should be regarded as the same entity. However, Pharmacare terminated and ceased to exist after the closing of its chapter 7 bankruptcy estate. The Chamberlin Corp. was a wholly separate organization that operated free and clear of Pharmacare's former debt, and any claims that petitioner had against Pharmacare *70 were resolved with that corporation's bankruptcy discharge. The latest date when the loss would have been realized was 1982, the year petitioner filed his claim against the bankruptcy estate of Pharmacare. At that point, he had no realistic possibility of recovery. See
The $ 450,000 loss, arising from the Freedom Federal loan proceeds, was realized by petitioner in 1985. A bad debt deduction is realized in the year it becomes worthless. See
Creditors of The *71 Chamberlin Corp. filed an involuntary petition in bankruptcy against the company on December 17, 1984. However, The Chamberlin Corp. continued to operate and sought outside investment in a quest to avoid involuntary bankruptcy until at least March 1985. Until the company accepted its involuntary bankruptcy fate in 1985, there was a reasonable possibility that the company could be saved and that petitioner could recover some or all of his $ 450,000 loan to The Chamberlin Corp. See
Personal Bankruptcy
Having decided the amount and timing of losses sustained by petitioners and the amount of losses sustained by their bankruptcy estate, the next issue for decision is the effect that petitioners' personal chapter 11 bankruptcy had on these losses.
Upon the filing of a voluntary chapter 11 petition in bankruptcy, certain tax attributes listed in
-- The estate shall succeed to and take into account the
following items (determined as of the *72 first day of the debtor's
taxable year in which the case commences) of the debtor --
(1) Net operating loss carryovers. -- The net
operating loss carryovers determined under section 172.
(2) Charitable contributions carryovers. -- The
carryover of excess charitable contributions determined
under section 170(d)(1).
(3) Recovery of tax benefits items. -- Any amount to
which section 111 (relating to recovery of tax benefit
items) applies.
(4) Credit carryovers, etc. -- The carryovers of any
credit, and all other items which, but for the commencement
of the case, would be required to be taken into account by
the debtor with respect to any credit.
(5) Capital loss carryovers. -- The capital loss
carryover determined under section 1212.
(6) Basis, holding period, and character of assets. --
In the case of any assets acquired (other than by sale or
exchange) by the estate from the debtor, the basis, holding
period, and character it had in the hands of the debtor.
(7) Method of accounting. -- The method of accounting
used by the debtor.
(8) Other attributes. -- Other tax attributes *73 of the
debtor, to the extent provided in regulations prescribed by
the Secretary as necessary or appropriate to carry out the
purposes of this section.
The bankruptcy estate uses any tax attribute received from the taxpayer plus its own attributes to reduce its taxable income. See
From 1982 until 1985, petitioners could not use any of their $ 1,255,400 carryover loss from Pharmacare to reduce taxable income. Under
The entire amount of loss is carried to the earliest taxable years to which such loss may be carried. See
The bankruptcy estate of petitioners did not file a tax return for 1985 and, therefore, did not use any allowable losses to offset taxable income in that year. During the later taxable years of the bankruptcy estate, 1986 to 1994, the bankruptcy estate filed tax returns but could not use any of the carryover *75 losses to reduce its income.
Petitioners have failed to produce the evidence necessary to calculate the taxable income of the bankruptcy estate for 1985, thus making it impossible to determine how much of the loss belonging to the bankruptcy estate was absorbed. Because we cannot determine whether any or all of the loss was absorbed by the bankruptcy estate, we conclude that petitioners have failed to prove that any amount thereof may be carried forward to the years in issue. However, even if we were to assume that the bankruptcy estate had no more income in 1985 than what the record before us reflects, the taxable income of the bankruptcy estate in 1985 would be more than enough to absorb completely $ 2,340,878 of deductible loss.
The bankruptcy trustee sold the personal residence of petitioners on August 20, 1985. The amount realized from the sale was equal to the $ 3,700,000 purchase price, and the adjusted basis was equal to the $ 530,000 cost basis. Although petitioner testified that he made several improvements to the property during his years of ownership that would adjust the basis upward, he presented no supporting receipts or documentation. Thus, the gain that was realized *76 by the bankruptcy estate was equal to $ 3,170,000. See sec. 1001(a).
Petitioners argue that the estate should be allowed to use the $ 125,000 one-time exclusion of gain under
The $ 3,170,000 of income from the sale of the personal residence in 1985 completely absorbs the $ 2,340,878 loss belonging to the bankruptcy estate. Thus, petitioners would have no carryover losses surviving the estate upon its termination to reduce petitioners' income during the years in issue. Having concluded that none of the losses belonging to the bankruptcy estate survived 1985, it is not necessary for us to determine their character.
CHARACTER OF THE $ 450,000 LOSS
Whether the $ 450,000 loss was a business bad debt under
Petitioners contend that, from 1978 until 1984, petitioner was engaged in the trade or business of promoting business ventures in the health care industry. Respondent argues that petitioner's dominant motive for acquiring and guaranteeing loans for The Chamberlin Corp. was for investment purposes and that the activities of petitioner with regard to his promotion of business ventures do not rise to the level of a trade or business.
In order to be engaged in carrying on a trade or business, the taxpayer must be involved in the activity with continuity and regularity, and the taxpayer's primary purpose for engaging in the activity must be for income or profit. See
In
Devoting one's time and energies to the affairs of a
corporation is not of itself, and without more, a trade or
business of the person so engaged. Though such activities may
produce income, profit or gain in the form of dividends or
enhancement in the value of an investment, this return is
distinctive to the process of investing and is generated by the
successful operation of the corporation's business as
distinguished from the trade or business of the taxpayer
himself. When the only return is that of an investor, the
taxpayer has not satisfied his burden of demonstrating that he
*80 is engaged in a trade or business since investing is not a trade
or business and the return to the taxpayer, though substantially
the product of his services, legally arises not from his own
trade or business but from that of the corporation. Even if the
taxpayer demonstrates an independent trade or business of his
own, care must be taken to distinguish bad debt losses arising
from his own business and those actually arising from activities
peculiar to an investor concerned with, and participating in,
the conduct of the corporate business.
If full-time service to one corporation does not alone
amount to a trade or business, which it does not, it is
difficult to understand how the same service to many
corporations would suffice. To be sure, the presence of more
than one corporation might lend support to a finding that the
taxpayer was engaged in a regular course of promoting
corporations for a fee or commission, * * * or for a profit on
their sale, * * * but in such cases there is compensation other
than the normal investor's return, income received directly for
his own services rather than indirectly through the corporate
enterprise * * *.
In
In
Petitioner has failed to show that he acquired his business ventures with an intent to sell them in the near future for profit. Instead, petitioner testified that he intended to build The Chamberlin Corp. into a much larger corporation and to hold the corporation for an extended amount of time. Petitioner testified that his motive for engaging in The Chamberlin Corp. venture was his belief that the demand for generic pharmaceuticals would steadily *83 increase throughout the 1980's and that anyone positioned in the generic pharmaceutical market would stand to make a large sum of money. Petitioner was not paid compensation for his services to the corporation. His activities are more analogous to those of an investor attempting to reap profits through dividends and the increase in value of his investment than to that of a promoter who buys and sells companies as if they were inventory. We conclude that petitioner was not in the trade or business of promoting business ventures in the health care industry. Thus, petitioners may not deduct as a business bad debt the $ 450,000 loss.
We have considered all other arguments of petitioners, and they are addressed by the consideration of lack of remaining carryover losses belonging to the bankruptcy estate or otherwise lack merit.
Additions to Tax and Penalties
Respondent determined additions to tax for failure to file tax returns under
ADDITIONS TO TAX FOR FAILURE TO FILE TIMELY A TAX RETURN AND PAY TAX LIABILITY
To escape the additions to tax for filing late returns, petitioners have the burden of proving that the failure to file did not result from willful neglect and that the failure was due to reasonable *85 cause. See
Petitioners argue that they used ordinary business care and prudence because they were acting at all times upon the advice of a certified public accountant who prepared their returns. Petitioners also claim that, due to their financial crisis at the time, any failure on their part to file returns or pay tax liability was unavoidable and excusable.
From 1982 to 1993, petitioners have shown a pattern of willful neglect in failing to file their Federal income tax returns in a timely manner. Although petitioners employed a paid tax preparer to prepare their returns, petitioners did not offer any evidence to show that the paid preparer was the cause of petitioners' failing to file and pay the tax shown on their returns on time. Also, petitioner is a well-educated individual who knew or should have known that a tax return was due in a timely fashion during all of the *86 years in issue. See
Petitioners maintain that they lost some of their financial records when they placed them in storage in 1985. Although the loss of records was an involuntary action, it does not relieve petitioners of their duty to file a timely return. See
NEGLIGENCE ADDITIONS TO TAX AND PENALTIES
Respondent determined negligence additions to tax or penalties for all of the years in issue. For 1985,
For the years in issue, petitioners must show that they acted reasonably and prudently and exercised due care in reporting their taxes. See id. Petitioners assert that their actions were not negligent, and, therefore, they are not liable for additions to tax or penalties. They argue that they relied on the advice of a certified public accountant in calculating their tax liability *88 during all years.
Taxpayers may satisfy their burden of proof as to negligence by showing that they reasonably relied on the advice of a competent professional adviser. See
Although any reliance by petitioners on the advice of their paid preparer was unreasonable with respect to the failure to file a timely return, it was reasonable to rely on the advice of the paid preparer regarding the amount of tax liability to report during the years in issue. The facts of this case created genuine issues as to whether petitioners are entitled to use NOL carryoverson their returns for 1985 through 1993. Due to the complexity of the bankruptcy issues involved, it was reasonable for petitioners to rely upon the incorrect advice of their paid preparer, who told them that they could deduct NOL's for their investments in and loans made to Pharmacare, The Chamberlin Corp., or Chamberlin *89 Parenteral. Therefore, petitioners are not liable for negligence penalties from 1985 through 1993.
SUBSTANTIAL UNDERSTATEMENT
Taxpayers are liable for penalties for substantial understatement of tax liability pursuant to
For the reasons previously discussed under the negligence analysis above, we conclude that petitioners' reliance on the tax liability calculated by their paid tax preparer was reasonable. Therefore, penalties for substantial understatement shall not apply.
To reflect the foregoing,
Decision will be entered under Rule 155.
1. 50% of the interest due upon these amounts.↩
Commissioner v. Groetzinger , 107 S. Ct. 980 ( 1987 )
Lone Manor Farms, Inc. v. Commissioner , 61 T.C. 436 ( 1974 )
Freytag v. Commissioner , 111 S. Ct. 2631 ( 1991 )
Morton v. Commissioner , 38 B.T.A. 1270 ( 1938 )
Brenner v. Commissioner , 62 T.C. 878 ( 1974 )
Malinowski v. Commissioner , 71 T.C. 1120 ( 1979 )
United States v. Boyle , 105 S. Ct. 687 ( 1985 )
thomas-l-freytag-and-sharon-n-freytag-v-commissioner-of-internal , 904 F.2d 1011 ( 1990 )
Welch v. Helvering , 54 S. Ct. 8 ( 1933 )
Whipple v. Commissioner , 83 S. Ct. 1168 ( 1963 )
Indopco, Inc. v. Commissioner , 112 S. Ct. 1039 ( 1992 )
Freytag v. Commissioner , 89 T.C. 849 ( 1987 )
Polakis v. Commissioner , 91 T.C. 660 ( 1988 )
Fincher v. Commissioner , 105 T.C. 126 ( 1995 )
Morton v. Commissioner of Internal Revenue , 112 F.2d 320 ( 1940 )